Clinical Trials Logo

Oxidative Stress clinical trials

View clinical trials related to Oxidative Stress.

Filter by:

NCT ID: NCT05127928 Completed - Oxidative Stress Clinical Trials

Antioxidants Vitamins and Muscle Damage

Antioxidant
Start date: February 10, 2022
Phase: N/A
Study type: Interventional

Determine if acute supplementation with antioxidant vitamins (vitamin C and vitamin E) influences the muscle damage and fatigue caused after an acute session of eccentric training.

NCT ID: NCT05098691 Completed - Oxidative Stress Clinical Trials

Early Onset Preeclampsia and Nectin-4

Start date: May 1, 2020
Phase:
Study type: Observational

Early-onset Preeclampsia (PE) is a pregnancy disorder which may present with adverse pregnancy outcomes. Nectin-4 is an adhesion molecule mainly expressed in placenta. This study aimed to evaluate the relationship between early onset Preeclampsia and serum Nectin 4 levels.

NCT ID: NCT05046145 Completed - Inflammation Clinical Trials

Effects of Non-invasive Neuromodulation on Food Desire, Chewing Pattern, Executive Functions and Oxidative Stress.

Start date: July 13, 2021
Phase: N/A
Study type: Interventional

From the change in self-regulation, memory is inhibited, allowing individuals to suppress or ignore unwanted or outdated associations and thus help to filter information relevant to dietary goals from irrelevant information. Provoking changes in neuroplasticity and cortical excitability contribute to the regulation of neural activity. Both could be modified by applying direct electrical current to the sensorimotor cortex, with polarity/current-dependent results, and their effect would last for hours after the end of stimulation. Transcranial Direct Current Stimulation (tDCS), translated into Portuguese as Estimulação Transcraniana por Corrente Contínua (ETCC) is a neuromodulating tool in which a low-intensity electrical current is applied to the scalp to modulate neuronal activity.

NCT ID: NCT05041179 Completed - Oxidative Stress Clinical Trials

Bioavailability of PRUVIN® and Its Effects in Healthy Subjects (INDIGO)

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

To evaluate the effect of different doses of PRUVIN® (N-acetylcysteine [NAC] and glycine) on reduced glutathione levels in healthy elderly subjects

NCT ID: NCT05014659 Completed - Oxidative Stress Clinical Trials

Creatine Monohydrate Supplementation and Vascular Endothelial Health

Start date: October 17, 2020
Phase: N/A
Study type: Interventional

To determine the effects of 4 weeks of creatine monohydrate supplementation on markers of macrovascular and microvascular function, cognitive performance, and physical performance.

NCT ID: NCT04959006 Completed - Oxidative Stress Clinical Trials

Investigating a Natural Antioxidant Food Product on Oxidative Stress in Recreationally Active Participants

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the short term use of olive extract polyphenols on markers of oxidative stress in response to acute endurance exercise in recreationally active, healthy volunteers.The study will be conducted under laboratory conditions following a 16 day supplemental period. Participants will be required to attend the laboratory for a pre-screening/familiarisation trial followed by assessments PRE (baseline, days 1,2) and POST intervention (days 18,19). Across the intervention, participants will maintain habitual dietary intake/ exercise training. Additionally participants will be randomised in a double-blinded manner to either a placebo or antioxidant-rich supplementation (olive extract water). It is hypothesised that the polyphenols (antioxidants) found within olive extract drink will enhance markers of recovery to an endurance exercise bout compared with the placebo drink.

NCT ID: NCT04912947 Completed - Oxidative Stress Clinical Trials

EValuation of the Antioxidant and Anti-inflammatory Capacity of Nutraceutical IMMU·SYSTEM Food Supplement (EVAANIS)

EVAANIS
Start date: October 30, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to verify the effectiveness of Nutraceutical IMMU·SYSTEM Dietary supplement in reducing the levels of oxidative stress and inflammation in a sample of healthy adult subjects with high baseline levels of oxidative stress.

NCT ID: NCT04900532 Completed - Inflammation Clinical Trials

Effects of Supplementation With Tocotrienol on Chronic Kidney Disease Patients

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the supplementation with tocotrienol, a vitamin E compound on inflammation, oxidative stress, and microbiota on Chronic Kidney Disease patients.

NCT ID: NCT04834219 Completed - Clinical trials for Myocardial Infarction

Off-Pump and On-Pump Techniques and Oxidative Stress in CABG Surgery

CABG
Start date: January 15, 2021
Phase:
Study type: Observational [Patient Registry]

CABG (coronary artery bypass graft) surgery is among the most common heart surgeries performed in the heart pump. In CABG surgery, operations performed on the beating heart without the use of CPB (off-pump) are frequently performed (30-60%) (1). To the best of our knowledge, there has been no study examining cerebral oxygenation values, oxidative stress levels and postoperative results in CABG operations.

NCT ID: NCT04785183 Completed - Oxidative Stress Clinical Trials

Antioxidant Effects of Melatonin in Preterm

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Preterm infants are at risk of free radical mediated diseases from oxidative stress (OS) injury. Melatonin (MEL) is a powerful antioxidant and scavenger of free radicals. In preterm neonates, melatonin deficiency has been reported. Several studies tested the efficacy of melatonin to counteract oxidative damage in diseases of newborns such as chronic lung disease, perinatal brain injury, necrotizing enterocolitis, retinopathy of prematurity and sepsis, giving promising results. In these studies, the dosages of melatonin varied over a wide range. The present study was designed to test the hypothesis that oral administration of melatonin reduced OS and consequentially, the occurrence of intraventricular haemorrhage (IVH), necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP) and bronchopulmonary dysplasia (BPD) in preterm newborns.